PCL Inc
PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers HiSU solution, an automated multi-immune diagnostic system that performs various diagnostics, high-speed tests including blood screening, multiple cancer screening, autoimmune testing, etc. It also provides antigen and antibody diagnostic kits, including PCLOK II anti-HIV/HCV/syphilis, and PC… Read more
PCL Inc (241820) - Total Assets
Latest total assets as of December 2024: ₩21.58 Billion KRW
Based on the latest financial reports, PCL Inc (241820) holds total assets worth ₩21.58 Billion KRW as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PCL Inc - Total Assets Trend (2015–2024)
This chart illustrates how PCL Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PCL Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
PCL Inc's total assets of ₩21.58 Billion consist of 36.1% current assets and 63.9% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 9.5% |
| Accounts Receivable | ₩3.10 Billion | 14.4% |
| Inventory | ₩133.60 Million | 0.6% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩0.00 | 0.0% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how PCL Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PCL Inc's current assets represent 36.1% of total assets in 2024, a decrease from 77.4% in 2015.
- Cash Position: Cash and equivalents constituted 9.5% of total assets in 2024, down from 62.7% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is accounts receivable at 14.4% of total assets.
PCL Inc Competitors by Total Assets
Key competitors of PCL Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
PCL Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - PCL Inc generates 0.06x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - PCL Inc is currently not profitable relative to its asset base.
PCL Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.70 | 1.55 | 1.97 |
| Quick Ratio | 0.69 | 1.08 | 1.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩-3.33 Billion | ₩ 11.25 Billion | ₩ 6.70 Billion |
PCL Inc - Advanced Valuation Insights
This section examines the relationship between PCL Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.51 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -65.3% |
| Total Assets | ₩21.58 Billion |
| Market Capitalization | $8.68 Million USD |
Valuation Analysis
Below Book Valuation: The market values PCL Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: PCL Inc's assets decreased by 65.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for PCL Inc (2015–2024)
The table below shows the annual total assets of PCL Inc from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩21.58 Billion | -65.31% |
| 2023-12-31 | ₩62.19 Billion | -29.28% |
| 2022-12-31 | ₩87.94 Billion | +10.90% |
| 2021-12-31 | ₩79.30 Billion | +82.04% |
| 2020-12-31 | ₩43.56 Billion | +176.65% |
| 2019-12-31 | ₩15.75 Billion | +48.25% |
| 2018-12-31 | ₩10.62 Billion | -33.09% |
| 2017-12-31 | ₩15.87 Billion | +78.30% |
| 2016-12-31 | ₩8.90 Billion | +35.35% |
| 2015-12-31 | ₩6.58 Billion | -- |